Berger RMF - Search Results

1

Prognostic factors in pediatric pulmonary arterial hypertension: A systematic review and meta-analysis.

Ploegstra MJ, Zijlstra WMH, Douwes JM, Hillege HL, Berger RMF. Ploegstra MJ, et al. Among authors: berger rmf. Int J Cardiol. 2015 Apr 1;184:198-207. doi: 10.1016/j.ijcard.2015.01.038. Epub 2015 Jan 27. Int J Cardiol. 2015. PMID: 25706327 Review.

2

Treprostinil in advanced experimental pulmonary hypertension: beneficial outcome without reversed pulmonary vascular remodeling.

van Albada ME, van Veghel R, Cromme-Dijkhuis AH, Schoemaker RG, Berger RM. van Albada ME, et al. J Cardiovasc Pharmacol. 2006 Nov;48(5):249-54. doi: 10.1097/01.fjc.0000248229.87510.9b. J Cardiovasc Pharmacol. 2006. PMID: 17110807

3

Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?

van Loon RL, Hoendermis ES, Duffels MG, Vonk-Noordegraaf A, Mulder BJ, Hillege HL, Berger RM. van Loon RL, et al. Am Heart J. 2007 Oct;154(4):776-82. doi: 10.1016/j.ahj.2007.06.003. Am Heart J. 2007. PMID: 17893008

4

Pulmonary arterial hypertension in congenital cardiac disease--the need for refinement of the Evian-Venice classification.

van Albada ME, Berger RM. van Albada ME, et al. Cardiol Young. 2008 Feb;18(1):10-7. doi: 10.1017/S1047951107001849. Epub 2008 Jan 21. Cardiol Young. 2008. PMID: 18205971 Review.

5

Biological serum markers in the management of pediatric pulmonary arterial hypertension.

Van Albada ME, Loot FG, Fokkema R, Roofthooft MT, Berger RM. Van Albada ME, et al. Pediatr Res. 2008 Mar;63(3):321-7. doi: 10.1203/PDR.0b013e318163a2e7. Pediatr Res. 2008. PMID: 18287971

6

Effect of bosentan on exercise capacity and quality of life in adults with pulmonary arterial hypertension associated with congenital heart disease with and without Down's syndrome.

Duffels MG, Vis JC, van Loon RL, Nieuwkerk PT, van Dijk AP, Hoendermis ES, de Bruin-Bon RH, Bouma BJ, Bresser P, Berger RM, Mulder BJ. Duffels MG, et al. Am J Cardiol. 2009 May 1;103(9):1309-15. doi: 10.1016/j.amjcard.2009.01.021. Epub 2009 Mar 13. Am J Cardiol. 2009. PMID: 19406277

7

Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis.

Berger RM, Beghetti M, Galiè N, Gatzoulis MA, Granton J, Lauer A, Chiossi E, Landzberg M. Berger RM, et al. Int J Cardiol. 2010 Oct 29;144(3):373-8. doi: 10.1016/j.ijcard.2009.04.037. Epub 2009 May 21. Int J Cardiol. 2010. PMID: 19464064 Clinical Trial.

8

Clinical characterization of pediatric pulmonary hypertension: complex presentation and diagnosis.

van Loon RL, Roofthooft MT, van Osch-Gevers M, Delhaas T, Strengers JL, Blom NA, Backx A, Berger RM. van Loon RL, et al. J Pediatr. 2009 Aug;155(2):176-82.e1. doi: 10.1016/j.jpeds.2009.02.036. Epub 2009 Jun 12. J Pediatr. 2009. PMID: 19524254

9

Gene expression profile in flow-associated pulmonary arterial hypertension with neointimal lesions.

van Albada ME, Bartelds B, Wijnberg H, Mohaupt S, Dickinson MG, Schoemaker RG, Kooi K, Gerbens F, Berger RM. van Albada ME, et al. Am J Physiol Lung Cell Mol Physiol. 2010 Apr;298(4):L483-91. doi: 10.1152/ajplung.00106.2009. Epub 2009 Dec 18. Am J Physiol Lung Cell Mol Physiol. 2010. PMID: 20023177 Free article.

10

Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies.

van Loon RL, Roofthooft MT, Delhaas T, van Osch-Gevers M, ten Harkel AD, Strengers JL, Backx A, Hillege HL, Berger RM. van Loon RL, et al. Am J Cardiol. 2010 Jul 1;106(1):117-24. doi: 10.1016/j.amjcard.2010.02.023. Am J Cardiol. 2010. PMID: 20609658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

220 results

Search Page